# AXL Breast Cancer - Batch 3 (Scenarios 5-6)
# Part 3 of comprehensive hypothesis testing

hypothesis: "AXL inhibition disrupts oncogenic signaling in breast cancer"

description: |
  Testing the effects of AXL receptor tyrosine kinase inhibition on
  downstream pathways - Batch 3 (Pathway Comparison + Drug Repurposing)

global_params:
  tissue_context: breast

scenarios:
  # Phase 5: Pathway Comparison
  - id: 5
    name: "AXL Pathway Comparison"
    pathway_query: "AXL pathway"

  # Phase 6: Drug Repurposing
  - id: 6
    name: "AXL Drug Repurposing"
    disease_query: "breast cancer"
    tissue_context: "breast"

# Output configuration
output:
  format: json
  visualization: true
